Baik, C. (2019, September 26). Update on EGFR-mutated non-small cell lung cancer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 12, 2019, from https://hstalks.com/bs/4038/.
Published on September 26, 2019
Dr. Christina Baik has given the following financial disclosures: Pfizer; Novartis; Celgene; Loxo Oncology; Genentech; Daiichi Sankyo; Blueprint Medicines; Spectrum; NIH/NCI – grant/research funding to institution. AstraZeneca; F. Hoffman-La Roche AG – grant/research funding to institution and consulting fees